#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary amyloidosis Haemophilia A without inhibitors Primary biliary cholangitis Facioscapulohumeral muscular dystrophy Cluster headache Fungal infection Gastrointestinal disorder Acute respiratory distress syndrome Pemphigus Cold type haemolytic anaemia Carcinoid tumour Systemic lupus erythematosus Alpha-1 antitrypsin deficiency Anal fistula Warm autoimmune haemolytic anaemia More trials…

    Learn about Rare Diseases

    Pituitary-dependent Cushing’s syndrome – Trials in Disease Progressive multifocal leukoencephalopathy – Diagnostics Gaucher’s disease type III – Diagnostics Haemophilia B without inhibitors – Diagnostics Alexander disease – Trials in Disease Angelman’s syndrome – Basic Information Synovial sarcoma – Diagnostics Lymphatic malformation Idiopathic pulmonary fibrosis – Diagnostics Behcet’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Carbetocin Antithymocyte Immunoglobulin Xanthum Gum Carbamazepine Fluticasone Propionate Belzupacap Sarotalocan Maralixibat Chloride Minoxidil Hydroxypropyl Cellulose Lf Sulpiride Tegafur Ranitidine Hydrochloride Io102 Hydrochloride Ivermectin Diltiazem Hydrochloride Thiamine Acetylcysteine Treg02 TUB-030 Efzofitimod More therapies…

    Learn about Your Condition

    Postprandial hypoglycaemia Tuberculosis Encephalitis autoimmune Immunodeficiency Choroidal dystrophy Hepatorenal syndrome BK virus infection Cerebrovascular accident Chondrocalcinosis Oesophagogastroscopy Normal pressure hydrocephalus Epiphysiolysis Clinically isolated syndrome Myelodysplastic syndrome Mantle cell lymphoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Squamous cell carcinoma of the vulva

  • Study on HPV Vaccine for Women with Vulvar HSIL: Evaluating the Effectiveness of Nonavalent HPV Vaccine in Preventing Recurrence of Vulvar High-Grade Lesions

    Recruiting

    3 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of the vulva
    Investigated Drugs:
    • Human Papillomavirus Type 11 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 16 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    • Human Papillomavirus Type 18 L1 Protein – Adsorbed – In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
    The Netherlands

  • Study of pembrolizumab and vorinostat combination therapy in patients with recurrent or metastatic squamous cell carcinoma of head and neck, cervix, anus, and genital areas

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Anal squamous cell carcinoma
    • Penile squamous cell carcinoma
    • Squamous cell carcinoma of the cervix
    Investigated Drugs:
    • Vorinostat
    • Pembrolizumab
    France

  • Study on the Safety and Effects of Durvalumab and Tremelimumab with Radiotherapy for Patients with Metastatic Squamous Cell Carcinoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Head and neck cancer metastatic
    • Lung squamous cell carcinoma metastatic
    • Metastatic squamous cell carcinoma
    Investigated Drugs:
    • Durvalumab
    • Tremelimumab
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!